Research Article Details
| Article ID: | A08051 |
| PMID: | 32268108 |
| Source: | Cell Metab |
| Title: | On the Front Line: Obesity and NAFLD. |
| Abstract: | In February, researchers convened in Banff, Canada, for the 2020 Keystone Symposium on Obesity and NAFLD. As the meeting wrapped up, we spoke with attendees, including key leaders, and they shared what was on the forefront of their minds-from the battle against NASH to emergent single-cell technologies. |
| DOI: | 10.1016/j.cmet.2020.03.014 |
| Strategy ID | Therapy Strategy | Synonyms | Therapy Targets | Therapy Drugs |
|---|
| Target ID | Target Name | GENE | Action | Class | UniProtKB ID | Entry Name |
|---|
| Diseases ID | DO ID | Disease Name | Definition | Class | |
|---|---|---|---|---|---|
| I14 | 9970 | Obesity | An overnutrition that is characterized by excess body fat, traditionally defined as an elevated ratio of weight to height (specifically 30 kilograms per meter squared), has_material_basis_in a multifactorial etiology related to excess nutrition intake, decreased caloric utilization, and genetic susceptibility, and possibly medications and certain disorders of metabolism, endocrine function, and mental illness. https://en.wikipedia.org/wiki/Obesity | disease of metabolism/acquired metabolic disease/ nutrition disease/overnutrition | Details |